Research ArticleHuman Studies
In Vivo Demonstration of Enzyme Activity in Endocrine Pancreatic Tumors: Decarboxylation of Carbon-11-DOPA to Carbon-11-Dopamine
Mats Bergström, Barbro Eriksson, Kjell Öberg, Anders Sundin, Håkan Ahlström, Karl Johan Lindner, Peter Bjurling and Bengt Långström
Journal of Nuclear Medicine January 1996, 37 (1) 32-37;
Mats Bergström
Barbro Eriksson
Kjell Öberg
Anders Sundin
Håkan Ahlström
Karl Johan Lindner
Peter Bjurling


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vivo Demonstration of Enzyme Activity in Endocrine Pancreatic Tumors: Decarboxylation of Carbon-11-DOPA to Carbon-11-Dopamine
Mats Bergström, Barbro Eriksson, Kjell Öberg, Anders Sundin, Håkan Ahlström, Karl Johan Lindner, Peter Bjurling, Bengt Långström
Journal of Nuclear Medicine Jan 1996, 37 (1) 32-37;
In Vivo Demonstration of Enzyme Activity in Endocrine Pancreatic Tumors: Decarboxylation of Carbon-11-DOPA to Carbon-11-Dopamine
Mats Bergström, Barbro Eriksson, Kjell Öberg, Anders Sundin, Håkan Ahlström, Karl Johan Lindner, Peter Bjurling, Bengt Långström
Journal of Nuclear Medicine Jan 1996, 37 (1) 32-37;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
- 6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications
- Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-L-DOPA
- Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis